Mode
Text Size
Log in / Sign up
N/A N=51 Randomized Double-blind Treatment

Passive Mobilization and Vascular Function

Endothelial Dysfunction · Aging · Bed Rest

Enrolled (actual)
51
Serious AEs
0.0%
Results posted
Aug 2019
Primary outcome: Primary: Change of Delta Peak Blood Flow During sPLM — 91.9; -24.7 ml/min — p=0.0492

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Passive mobilization - PM (Other)
Age
Older Adult · 65+ yrs
Sex
All
Sponsor
Universita di Verona
Primary completion
Jun 2017

Outcome Measures

OutcomeResultp-value
PRIMARY
Change of Delta Peak Blood Flow During sPLM
91.9; -24.7 0.0492 sig
PRIMARY
Change of % FMD
0.2; 0.0 0.0283 sig
SECONDARY
Change of Total Hemoglobin
-12.5; -2.2 0.0321 sig
SECONDARY
Change of Range of Motion
13.13; 3.93 0.0451 sig
SECONDARY
Change of Thickness of Vastus Lateralis
0.53; 0.25 0.0476 sig

Summary

With aging, vascular function (VF) declines. Inactivity and sedentary life style have been shown to contribute to the worsening of VF. Furthermore, bed rest, a condition commonly used for the management of many chronic conditions, has been proven to lead to even more deleterious consequences, including VF decline. This study evaluates the effect of passive mobilization of the lower limbs on VF in bedridden oldest-old. Half of the participants will undergo passive mobilization treatment in addition to standard therapies, while the other half will receive only standard therapies. We hypothesize that passive mobilization may improve nitric oxide (NO)-mediated endothelial function.

Eligibility Criteria

Inclusion Criteria

  • Bedridden

Exclusion Criteria

  • Neurodegenerative disease (i.e.Parkinson's disease, Alzheimer's disease)
  • Heart failure
  • Organ transplantation
  • Liver failure
  • Kidney failure
  • Hemorrhage
  • Neuromuscular diseases
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03087643). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search